Taufiek Konrad Rajab
Concepts (475)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Heart Transplantation | 39 | 2024 | 344 | 19.140 |
Why?
| Heart Valve Prosthesis | 11 | 2024 | 76 | 6.590 |
Why?
| Heart Valve Prosthesis Implantation | 11 | 2024 | 78 | 5.970 |
Why?
| Tissue Adhesions | 25 | 2021 | 31 | 5.900 |
Why?
| Lung Transplantation | 10 | 2022 | 37 | 4.540 |
Why?
| Tissue Donors | 13 | 2024 | 113 | 3.900 |
Why?
| Heart Valves | 9 | 2024 | 24 | 3.730 |
Why?
| Aortic Valve | 14 | 2024 | 112 | 3.410 |
Why?
| Cardiac Surgical Procedures | 9 | 2024 | 295 | 3.150 |
Why?
| Tissue and Organ Procurement | 7 | 2024 | 41 | 3.100 |
Why?
| Pulmonary Valve | 5 | 2024 | 45 | 2.980 |
Why?
| Heart Defects, Congenital | 10 | 2024 | 585 | 2.950 |
Why?
| Heart Valve Diseases | 7 | 2024 | 47 | 2.590 |
Why?
| Organ Transplantation | 5 | 2024 | 47 | 2.570 |
Why?
| Postoperative Complications | 13 | 2022 | 996 | 2.490 |
Why?
| Bioprosthesis | 4 | 2023 | 35 | 2.470 |
Why?
| Humans | 113 | 2024 | 50208 | 2.400 |
Why?
| Echocardiography | 8 | 2024 | 375 | 2.190 |
Why?
| Bioartificial Organs | 3 | 2020 | 3 | 2.120 |
Why?
| Models, Animal | 8 | 2024 | 232 | 2.020 |
Why?
| Lung | 7 | 2022 | 490 | 1.970 |
Why?
| Thrombosis | 3 | 2023 | 248 | 1.940 |
Why?
| Extracorporeal Membrane Oxygenation | 4 | 2023 | 289 | 1.890 |
Why?
| Peritoneal Diseases | 8 | 2013 | 15 | 1.850 |
Why?
| Graft Rejection | 9 | 2024 | 168 | 1.850 |
Why?
| Peritoneum | 8 | 2017 | 17 | 1.800 |
Why?
| Truncus Arteriosus, Persistent | 2 | 2024 | 7 | 1.780 |
Why?
| Transplantation, Heterologous | 5 | 2024 | 75 | 1.750 |
Why?
| Transplants | 2 | 2023 | 19 | 1.730 |
Why?
| Tissue Scaffolds | 5 | 2020 | 34 | 1.710 |
Why?
| Biocompatible Materials | 7 | 2019 | 69 | 1.690 |
Why?
| Animals | 44 | 2024 | 13246 | 1.670 |
Why?
| Child | 20 | 2024 | 6851 | 1.630 |
Why?
| Tissue Engineering | 4 | 2020 | 65 | 1.630 |
Why?
| Organ Preservation | 2 | 2022 | 23 | 1.520 |
Why?
| Aortic Valve Stenosis | 3 | 2021 | 62 | 1.490 |
Why?
| Norwood Procedures | 2 | 2021 | 56 | 1.440 |
Why?
| Heart Failure | 8 | 2024 | 506 | 1.400 |
Why?
| Heart Neoplasms | 3 | 2019 | 33 | 1.400 |
Why?
| Swine | 11 | 2024 | 396 | 1.390 |
Why?
| Hypoplastic Left Heart Syndrome | 2 | 2021 | 93 | 1.380 |
Why?
| Thoracic Surgery | 3 | 2017 | 16 | 1.290 |
Why?
| Suture Techniques | 4 | 2014 | 59 | 1.280 |
Why?
| Heart-Assist Devices | 4 | 2024 | 150 | 1.230 |
Why?
| Transplantation, Homologous | 6 | 2023 | 138 | 1.210 |
Why?
| Disease Models, Animal | 12 | 2024 | 1458 | 1.200 |
Why?
| Ischemia | 3 | 2014 | 153 | 1.200 |
Why?
| Aortic Valve Insufficiency | 3 | 2022 | 21 | 1.170 |
Why?
| Heart Atria | 3 | 2023 | 56 | 1.150 |
Why?
| Perfusion | 4 | 2022 | 48 | 1.130 |
Why?
| Rats | 19 | 2024 | 3299 | 1.120 |
Why?
| Tourniquets | 2 | 2023 | 9 | 1.080 |
Why?
| Forecasting | 3 | 2024 | 150 | 1.060 |
Why?
| Infant, Newborn | 11 | 2024 | 2766 | 1.020 |
Why?
| Rodentia | 2 | 2024 | 18 | 1.020 |
Why?
| Death | 3 | 2020 | 21 | 0.980 |
Why?
| Adult | 28 | 2024 | 13324 | 0.970 |
Why?
| Treatment Outcome | 20 | 2024 | 5155 | 0.960 |
Why?
| Internship and Residency | 5 | 2017 | 441 | 0.950 |
Why?
| Vitrification | 1 | 2024 | 4 | 0.940 |
Why?
| Female | 43 | 2024 | 26635 | 0.940 |
Why?
| Cryoprotective Agents | 1 | 2024 | 6 | 0.930 |
Why?
| Out-of-Hospital Cardiac Arrest | 2 | 2021 | 26 | 0.930 |
Why?
| Shock, Hemorrhagic | 2 | 2014 | 11 | 0.920 |
Why?
| Pelvic Bones | 2 | 2014 | 11 | 0.920 |
Why?
| Cryopreservation | 1 | 2024 | 31 | 0.910 |
Why?
| Immunosuppressive Agents | 2 | 2022 | 222 | 0.900 |
Why?
| Aortic Diseases | 2 | 2022 | 54 | 0.890 |
Why?
| Vena Cava, Superior | 1 | 2023 | 22 | 0.890 |
Why?
| Coronary Vessel Anomalies | 1 | 2024 | 38 | 0.890 |
Why?
| Hyaluronic Acid | 4 | 2017 | 34 | 0.860 |
Why?
| Follow-Up Studies | 10 | 2023 | 2190 | 0.860 |
Why?
| Fractures, Bone | 2 | 2014 | 106 | 0.840 |
Why?
| Coronary Artery Bypass | 4 | 2019 | 122 | 0.820 |
Why?
| Rats, Wistar | 12 | 2017 | 222 | 0.790 |
Why?
| Puerperal Disorders | 3 | 2018 | 28 | 0.780 |
Why?
| Biological Evolution | 1 | 2021 | 32 | 0.770 |
Why?
| Informed Consent | 2 | 2013 | 97 | 0.760 |
Why?
| Heart Arrest | 1 | 2023 | 151 | 0.750 |
Why?
| Polymers | 1 | 2020 | 41 | 0.740 |
Why?
| Airway Extubation | 1 | 2021 | 30 | 0.740 |
Why?
| Coronary Aneurysm | 2 | 2010 | 18 | 0.730 |
Why?
| Male | 28 | 2024 | 25399 | 0.700 |
Why?
| Cardiopulmonary Resuscitation | 1 | 2021 | 135 | 0.690 |
Why?
| Fontan Procedure | 1 | 2020 | 62 | 0.690 |
Why?
| Eisenmenger Complex | 1 | 2019 | 2 | 0.680 |
Why?
| Heart-Lung Transplantation | 1 | 2019 | 2 | 0.680 |
Why?
| Dextrocardia | 1 | 2019 | 4 | 0.680 |
Why?
| Paraganglioma | 1 | 2019 | 14 | 0.680 |
Why?
| Fellowships and Scholarships | 2 | 2017 | 111 | 0.680 |
Why?
| Tracheal Stenosis | 1 | 2019 | 12 | 0.670 |
Why?
| Practice Guidelines as Topic | 2 | 2020 | 449 | 0.660 |
Why?
| Heart Septal Defects, Atrial | 1 | 2019 | 45 | 0.660 |
Why?
| Evidence-Based Medicine | 1 | 2020 | 247 | 0.660 |
Why?
| Infant | 7 | 2024 | 3563 | 0.650 |
Why?
| Soybean Oil | 1 | 2018 | 4 | 0.640 |
Why?
| Trachea | 1 | 2019 | 52 | 0.640 |
Why?
| Surgical Procedures, Operative | 2 | 2010 | 63 | 0.640 |
Why?
| Proctoscopy | 1 | 2018 | 2 | 0.630 |
Why?
| Digital Rectal Examination | 1 | 2018 | 3 | 0.630 |
Why?
| Phospholipids | 1 | 2018 | 57 | 0.620 |
Why?
| Coronary Stenosis | 1 | 2019 | 99 | 0.600 |
Why?
| Reperfusion Injury | 1 | 2018 | 87 | 0.600 |
Why?
| Abnormalities, Multiple | 1 | 2019 | 167 | 0.600 |
Why?
| Retrospective Studies | 14 | 2022 | 6134 | 0.580 |
Why?
| Travel | 1 | 2017 | 37 | 0.580 |
Why?
| Pneumonia, Viral | 1 | 2020 | 169 | 0.570 |
Why?
| Coronavirus Infections | 1 | 2020 | 178 | 0.560 |
Why?
| Aorta | 3 | 2024 | 162 | 0.560 |
Why?
| Abdominal Wall | 3 | 2021 | 12 | 0.550 |
Why?
| Percutaneous Coronary Intervention | 1 | 2020 | 301 | 0.550 |
Why?
| Education, Medical, Graduate | 2 | 2017 | 205 | 0.530 |
Why?
| Oxygen | 1 | 2018 | 325 | 0.520 |
Why?
| General Surgery | 2 | 2016 | 106 | 0.510 |
Why?
| Pandemics | 1 | 2020 | 562 | 0.510 |
Why?
| Cardiovascular Diseases | 1 | 2020 | 443 | 0.510 |
Why?
| Anticoagulants | 3 | 2023 | 253 | 0.490 |
Why?
| Laparoscopy | 4 | 2010 | 168 | 0.490 |
Why?
| Surgical Instruments | 2 | 2015 | 28 | 0.470 |
Why?
| Intraoperative Period | 1 | 2014 | 45 | 0.460 |
Why?
| Lasers, Semiconductor | 1 | 2013 | 10 | 0.450 |
Why?
| Hypotension | 1 | 2014 | 63 | 0.440 |
Why?
| Polycystic Kidney, Autosomal Dominant | 1 | 2013 | 5 | 0.440 |
Why?
| Transplantation, Heterotopic | 2 | 2024 | 7 | 0.440 |
Why?
| Femoral Artery | 1 | 2014 | 102 | 0.440 |
Why?
| Hemodynamics | 4 | 2023 | 263 | 0.440 |
Why?
| Middle Aged | 14 | 2024 | 12206 | 0.440 |
Why?
| Coronary Angiography | 3 | 2024 | 355 | 0.430 |
Why?
| Transplantation, Autologous | 3 | 2020 | 469 | 0.420 |
Why?
| Surgery, Computer-Assisted | 1 | 2013 | 56 | 0.420 |
Why?
| Pregnancy, Ectopic | 2 | 2009 | 9 | 0.420 |
Why?
| Jejunum | 1 | 2012 | 54 | 0.420 |
Why?
| Endoscopy | 1 | 2013 | 124 | 0.410 |
Why?
| Polyesters | 2 | 2010 | 8 | 0.410 |
Why?
| Hyperglycemia | 1 | 2012 | 78 | 0.410 |
Why?
| Prednisolone | 1 | 2012 | 55 | 0.410 |
Why?
| Electrocoagulation | 2 | 2009 | 12 | 0.410 |
Why?
| Coronary Vessels | 2 | 2010 | 157 | 0.410 |
Why?
| Abdominal Injuries | 2 | 2012 | 36 | 0.400 |
Why?
| Biomedical Engineering | 3 | 2020 | 4 | 0.400 |
Why?
| Enteral Nutrition | 1 | 2012 | 147 | 0.400 |
Why?
| Receptors, Tachykinin | 1 | 2011 | 2 | 0.400 |
Why?
| Pericardiectomy | 1 | 2011 | 6 | 0.400 |
Why?
| Pericarditis, Constrictive | 1 | 2011 | 3 | 0.400 |
Why?
| Tomography, X-Ray Computed | 5 | 2020 | 1161 | 0.390 |
Why?
| Hernia, Umbilical | 1 | 2011 | 19 | 0.390 |
Why?
| Adolescent | 6 | 2024 | 6390 | 0.390 |
Why?
| Syphilis, Cardiovascular | 1 | 2011 | 2 | 0.390 |
Why?
| Glucose | 3 | 2012 | 338 | 0.390 |
Why?
| Myxoma | 1 | 2011 | 16 | 0.380 |
Why?
| Kidney Transplantation | 1 | 2013 | 175 | 0.380 |
Why?
| Anti-Inflammatory Agents | 1 | 2012 | 160 | 0.380 |
Why?
| Aortic Aneurysm, Thoracic | 1 | 2011 | 23 | 0.370 |
Why?
| Angina Pectoris | 1 | 2010 | 20 | 0.370 |
Why?
| Microsurgery | 1 | 2010 | 30 | 0.360 |
Why?
| Anastomosis, Surgical | 1 | 2010 | 66 | 0.360 |
Why?
| Aorta, Abdominal | 1 | 2010 | 41 | 0.360 |
Why?
| Vena Cava, Inferior | 1 | 2010 | 79 | 0.350 |
Why?
| Glucans | 2 | 2010 | 10 | 0.350 |
Why?
| Incidence | 3 | 2023 | 1006 | 0.340 |
Why?
| Bioengineering | 2 | 2020 | 3 | 0.340 |
Why?
| RNA, Messenger | 3 | 2012 | 1108 | 0.340 |
Why?
| Hemangioma | 1 | 2010 | 83 | 0.340 |
Why?
| Child, Preschool | 3 | 2023 | 3883 | 0.340 |
Why?
| Consent Forms | 1 | 2009 | 6 | 0.330 |
Why?
| United States | 10 | 2024 | 4874 | 0.330 |
Why?
| Cautery | 1 | 2008 | 3 | 0.330 |
Why?
| Gels | 1 | 2008 | 21 | 0.320 |
Why?
| Text Messaging | 1 | 2009 | 19 | 0.320 |
Why?
| Ovary | 1 | 2009 | 115 | 0.320 |
Why?
| Sutures | 1 | 2008 | 40 | 0.320 |
Why?
| Blood Pressure | 3 | 2023 | 524 | 0.320 |
Why?
| Tuberculosis, Spinal | 1 | 2008 | 5 | 0.310 |
Why?
| Vascular Surgical Procedures | 1 | 2010 | 164 | 0.310 |
Why?
| Reoperation | 2 | 2021 | 454 | 0.310 |
Why?
| Hydrogels | 1 | 2008 | 16 | 0.310 |
Why?
| Polyglutamic Acid | 1 | 2008 | 1 | 0.310 |
Why?
| Cellulose, Oxidized | 1 | 2008 | 4 | 0.310 |
Why?
| Low Back Pain | 1 | 2008 | 26 | 0.300 |
Why?
| Skin, Artificial | 1 | 2007 | 10 | 0.300 |
Why?
| Ontario | 2 | 2017 | 49 | 0.300 |
Why?
| Gelatin | 1 | 2007 | 22 | 0.300 |
Why?
| Uterine Diseases | 1 | 2007 | 10 | 0.300 |
Why?
| Pregnancy | 7 | 2023 | 2604 | 0.300 |
Why?
| Young Adult | 6 | 2024 | 3981 | 0.300 |
Why?
| Physician-Patient Relations | 1 | 2009 | 141 | 0.290 |
Why?
| Stents | 3 | 2020 | 343 | 0.290 |
Why?
| Skin Transplantation | 1 | 2007 | 44 | 0.290 |
Why?
| Lumbar Vertebrae | 1 | 2008 | 98 | 0.290 |
Why?
| Patient Satisfaction | 1 | 2009 | 275 | 0.290 |
Why?
| Pericardium | 2 | 2021 | 29 | 0.290 |
Why?
| Patient Education as Topic | 1 | 2010 | 313 | 0.280 |
Why?
| Heart Arrest, Induced | 2 | 2017 | 7 | 0.280 |
Why?
| Waiting Lists | 2 | 2024 | 54 | 0.280 |
Why?
| Radiography | 3 | 2013 | 491 | 0.270 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 486 | 0.260 |
Why?
| Materials Testing | 2 | 2020 | 58 | 0.260 |
Why?
| Attitude of Health Personnel | 1 | 2009 | 351 | 0.260 |
Why?
| Aged | 8 | 2023 | 9405 | 0.250 |
Why?
| Burns | 1 | 2007 | 163 | 0.250 |
Why?
| Physicians | 1 | 2009 | 230 | 0.250 |
Why?
| Graft Survival | 2 | 2022 | 150 | 0.240 |
Why?
| Papio | 1 | 2024 | 16 | 0.240 |
Why?
| Mycoplasma hyorhinis | 1 | 2024 | 1 | 0.240 |
Why?
| Thermography | 2 | 2017 | 11 | 0.240 |
Why?
| Mycoplasma Infections | 1 | 2024 | 7 | 0.240 |
Why?
| Tissue Banks | 1 | 2024 | 8 | 0.240 |
Why?
| Myocardium | 3 | 2011 | 438 | 0.230 |
Why?
| Endocarditis, Bacterial | 1 | 2024 | 45 | 0.230 |
Why?
| Membranes, Artificial | 3 | 2017 | 15 | 0.220 |
Why?
| Aorta, Thoracic | 1 | 2024 | 92 | 0.220 |
Why?
| Primates | 1 | 2023 | 20 | 0.220 |
Why?
| Regeneration | 2 | 2021 | 72 | 0.220 |
Why?
| Blood Coagulation | 1 | 2023 | 56 | 0.220 |
Why?
| Rats, Sprague-Dawley | 3 | 2018 | 1586 | 0.220 |
Why?
| Thigh | 1 | 2023 | 34 | 0.210 |
Why?
| HLA Antigens | 1 | 2023 | 53 | 0.210 |
Why?
| Mycophenolic Acid | 1 | 2022 | 18 | 0.210 |
Why?
| Peritoneal Cavity | 2 | 2013 | 8 | 0.210 |
Why?
| Prosthesis Design | 2 | 2020 | 237 | 0.200 |
Why?
| Lower Extremity | 1 | 2023 | 88 | 0.200 |
Why?
| Tacrolimus | 1 | 2022 | 52 | 0.200 |
Why?
| Transposition of Great Vessels | 1 | 2022 | 25 | 0.200 |
Why?
| Vascular Diseases | 1 | 2022 | 74 | 0.200 |
Why?
| Rats, Inbred Lew | 2 | 2019 | 69 | 0.200 |
Why?
| Blood Group Incompatibility | 1 | 2021 | 5 | 0.200 |
Why?
| Pentalogy of Cantrell | 1 | 2021 | 1 | 0.200 |
Why?
| Polytetrafluoroethylene | 1 | 2021 | 32 | 0.200 |
Why?
| Referral and Consultation | 1 | 2024 | 285 | 0.200 |
Why?
| Thorax | 1 | 2021 | 16 | 0.190 |
Why?
| Electric Impedance | 1 | 2021 | 41 | 0.190 |
Why?
| Diverticulum | 1 | 2021 | 21 | 0.190 |
Why?
| Propensity Score | 2 | 2019 | 122 | 0.190 |
Why?
| Mitral Valve | 1 | 2021 | 49 | 0.190 |
Why?
| Infant, Premature, Diseases | 1 | 2022 | 94 | 0.190 |
Why?
| Heart Septal Defects, Ventricular | 1 | 2021 | 41 | 0.190 |
Why?
| Metastasectomy | 1 | 2021 | 2 | 0.190 |
Why?
| Age Factors | 2 | 2024 | 1092 | 0.190 |
Why?
| Abdomen | 2 | 2012 | 77 | 0.190 |
Why?
| Digestive System Surgical Procedures | 2 | 2012 | 33 | 0.180 |
Why?
| Magnetic Resonance Imaging, Cine | 2 | 2019 | 55 | 0.180 |
Why?
| Dyspnea | 2 | 2011 | 75 | 0.180 |
Why?
| Premature Birth | 1 | 2022 | 147 | 0.180 |
Why?
| Brain Death | 1 | 2020 | 18 | 0.180 |
Why?
| Graft vs Host Disease | 1 | 2020 | 75 | 0.180 |
Why?
| History, 21st Century | 1 | 2020 | 55 | 0.180 |
Why?
| Sarcoma | 1 | 2021 | 67 | 0.170 |
Why?
| Postoperative Period | 1 | 2020 | 168 | 0.170 |
Why?
| Infant, Newborn, Diseases | 1 | 2020 | 57 | 0.170 |
Why?
| Heart | 2 | 2020 | 331 | 0.170 |
Why?
| Ankle Injuries | 1 | 2019 | 10 | 0.170 |
Why?
| Equipment Design | 1 | 2020 | 285 | 0.170 |
Why?
| History, 20th Century | 1 | 2020 | 99 | 0.170 |
Why?
| Pulsatile Flow | 1 | 2019 | 18 | 0.170 |
Why?
| Ventricular Fibrillation | 1 | 2019 | 16 | 0.170 |
Why?
| Islets of Langerhans | 1 | 2019 | 24 | 0.160 |
Why?
| Radiography, Thoracic | 1 | 2019 | 65 | 0.160 |
Why?
| Interdisciplinary Communication | 1 | 2019 | 55 | 0.160 |
Why?
| Survival Analysis | 1 | 2021 | 666 | 0.160 |
Why?
| Health Services Needs and Demand | 1 | 2020 | 158 | 0.160 |
Why?
| Temperature | 1 | 2019 | 168 | 0.160 |
Why?
| Emulsions | 1 | 2018 | 25 | 0.160 |
Why?
| Fat Emulsions, Intravenous | 1 | 2018 | 12 | 0.160 |
Why?
| Proctoscopes | 1 | 2018 | 1 | 0.160 |
Why?
| Palliative Care | 1 | 2020 | 186 | 0.160 |
Why?
| Anal Canal | 1 | 2018 | 21 | 0.160 |
Why?
| Heart, Artificial | 1 | 2018 | 3 | 0.160 |
Why?
| Comorbidity | 1 | 2020 | 613 | 0.160 |
Why?
| Colistin | 1 | 2018 | 3 | 0.160 |
Why?
| Polysaccharides | 1 | 2018 | 51 | 0.150 |
Why?
| Prospective Studies | 2 | 2023 | 2379 | 0.150 |
Why?
| Marfan Syndrome | 1 | 2018 | 24 | 0.150 |
Why?
| Operative Time | 2 | 2015 | 73 | 0.150 |
Why?
| Pneumonia, Bacterial | 1 | 2018 | 27 | 0.150 |
Why?
| Infrared Rays | 1 | 2017 | 25 | 0.150 |
Why?
| Pseudomonas Infections | 1 | 2018 | 48 | 0.150 |
Why?
| Cecum | 2 | 2008 | 63 | 0.150 |
Why?
| Extracellular Matrix | 1 | 2018 | 111 | 0.150 |
Why?
| Pseudomonas aeruginosa | 1 | 2018 | 72 | 0.150 |
Why?
| Stem Cells | 1 | 2019 | 171 | 0.150 |
Why?
| Colorectal Neoplasms | 1 | 2021 | 236 | 0.150 |
Why?
| Heparin | 1 | 2018 | 92 | 0.150 |
Why?
| Prosthesis Implantation | 1 | 2018 | 46 | 0.150 |
Why?
| Monitoring, Intraoperative | 1 | 2017 | 54 | 0.150 |
Why?
| Optical Imaging | 1 | 2017 | 25 | 0.150 |
Why?
| Aged, 80 and over | 3 | 2020 | 3154 | 0.140 |
Why?
| Gram-Positive Bacterial Infections | 1 | 2017 | 26 | 0.140 |
Why?
| Cell Proliferation | 1 | 2021 | 1013 | 0.140 |
Why?
| Combined Modality Therapy | 1 | 2019 | 636 | 0.140 |
Why?
| Endocarditis, Non-Infective | 1 | 2016 | 1 | 0.140 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 39 | 0.140 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2019 | 201 | 0.130 |
Why?
| Thoracoplasty | 1 | 2016 | 3 | 0.130 |
Why?
| Funnel Chest | 1 | 2016 | 10 | 0.130 |
Why?
| Ligation | 2 | 2013 | 59 | 0.130 |
Why?
| Potassium Compounds | 1 | 2015 | 2 | 0.130 |
Why?
| Prosthesis-Related Infections | 1 | 2017 | 105 | 0.130 |
Why?
| Antigens, CD | 1 | 2016 | 221 | 0.130 |
Why?
| Wounds and Injuries | 2 | 2008 | 281 | 0.130 |
Why?
| Lung Diseases | 1 | 2016 | 93 | 0.130 |
Why?
| Epithelium | 2 | 2012 | 65 | 0.130 |
Why?
| Lidocaine | 1 | 2015 | 50 | 0.120 |
Why?
| Lung Neoplasms | 1 | 2021 | 605 | 0.120 |
Why?
| Risk Assessment | 1 | 2019 | 1262 | 0.120 |
Why?
| Myocardial Contraction | 2 | 2011 | 107 | 0.120 |
Why?
| Curriculum | 1 | 2017 | 400 | 0.120 |
Why?
| Risk Factors | 2 | 2020 | 3629 | 0.120 |
Why?
| Macrophages | 1 | 2016 | 363 | 0.120 |
Why?
| Survival Rate | 3 | 2021 | 901 | 0.110 |
Why?
| Free Tissue Flaps | 1 | 2015 | 64 | 0.110 |
Why?
| Germany | 2 | 2010 | 24 | 0.110 |
Why?
| Esophagectomy | 1 | 2014 | 36 | 0.110 |
Why?
| Time Factors | 5 | 2024 | 2922 | 0.110 |
Why?
| Cell Adhesion | 2 | 2016 | 158 | 0.110 |
Why?
| Bandages | 1 | 2013 | 25 | 0.110 |
Why?
| Laparotomy | 1 | 2013 | 34 | 0.110 |
Why?
| Clinical Competence | 1 | 2016 | 392 | 0.110 |
Why?
| Heart Diseases | 1 | 2015 | 211 | 0.110 |
Why?
| Gastric Bypass | 1 | 2012 | 19 | 0.110 |
Why?
| Esophageal Neoplasms | 1 | 2014 | 100 | 0.110 |
Why?
| Pyruvate Dehydrogenase (Lipoamide) | 1 | 2012 | 1 | 0.100 |
Why?
| Histocytochemistry | 1 | 2012 | 47 | 0.100 |
Why?
| Injections, Intraperitoneal | 1 | 2012 | 55 | 0.100 |
Why?
| Succinate Dehydrogenase | 1 | 2012 | 23 | 0.100 |
Why?
| Intraoperative Care | 1 | 2012 | 54 | 0.100 |
Why?
| Preoperative Care | 1 | 2013 | 166 | 0.100 |
Why?
| Cystadenoma, Serous | 1 | 2012 | 5 | 0.100 |
Why?
| Foreign-Body Reaction | 3 | 2017 | 9 | 0.100 |
Why?
| Pancreatic Ducts | 1 | 2012 | 12 | 0.100 |
Why?
| Statistics, Nonparametric | 1 | 2012 | 193 | 0.100 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 56 | 0.100 |
Why?
| Pilot Projects | 2 | 2011 | 697 | 0.100 |
Why?
| Isoproterenol | 1 | 2011 | 56 | 0.100 |
Why?
| Second-Look Surgery | 1 | 2011 | 3 | 0.100 |
Why?
| Random Allocation | 1 | 2012 | 282 | 0.100 |
Why?
| Acidosis | 1 | 2011 | 40 | 0.100 |
Why?
| Ascites | 1 | 2011 | 28 | 0.100 |
Why?
| Diagnosis, Differential | 3 | 2012 | 1043 | 0.100 |
Why?
| Biological Science Disciplines | 1 | 2011 | 1 | 0.100 |
Why?
| Endocardium | 1 | 2011 | 7 | 0.100 |
Why?
| Lasers, Excimer | 1 | 2011 | 3 | 0.100 |
Why?
| Cardiotonic Agents | 1 | 2011 | 82 | 0.090 |
Why?
| Phrenic Nerve | 1 | 2011 | 6 | 0.090 |
Why?
| Heart Injuries | 1 | 2011 | 15 | 0.090 |
Why?
| Mammary Arteries | 1 | 2010 | 8 | 0.090 |
Why?
| AMP-Activated Protein Kinases | 1 | 2010 | 29 | 0.090 |
Why?
| Alopecia | 1 | 2011 | 39 | 0.090 |
Why?
| Tinnitus | 1 | 2011 | 60 | 0.090 |
Why?
| Infertility | 1 | 2010 | 17 | 0.090 |
Why?
| Scoliosis | 1 | 2011 | 60 | 0.090 |
Why?
| Fibrosis | 3 | 2017 | 180 | 0.090 |
Why?
| Laser Therapy | 1 | 2011 | 84 | 0.090 |
Why?
| Disclosure | 1 | 2010 | 39 | 0.090 |
Why?
| Leiomyoma | 1 | 2010 | 25 | 0.090 |
Why?
| Intestinal Obstruction | 1 | 2010 | 36 | 0.090 |
Why?
| Fallopian Tubes | 1 | 2009 | 22 | 0.090 |
Why?
| Electrosurgery | 1 | 2009 | 7 | 0.090 |
Why?
| Wounds, Nonpenetrating | 1 | 2011 | 80 | 0.090 |
Why?
| Adenocarcinoma | 1 | 2014 | 397 | 0.090 |
Why?
| Chi-Square Distribution | 1 | 2010 | 278 | 0.090 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2010 | 202 | 0.090 |
Why?
| Uterine Neoplasms | 1 | 2010 | 60 | 0.090 |
Why?
| Cardiomyopathies | 1 | 2010 | 116 | 0.080 |
Why?
| Myocardial Ischemia | 1 | 2010 | 121 | 0.080 |
Why?
| Triplets | 1 | 2009 | 1 | 0.080 |
Why?
| Pancreatic Neoplasms | 1 | 2012 | 208 | 0.080 |
Why?
| Vagina | 1 | 2009 | 45 | 0.080 |
Why?
| Serous Membrane | 1 | 2008 | 3 | 0.080 |
Why?
| Hot Temperature | 1 | 2009 | 205 | 0.080 |
Why?
| Confidentiality | 1 | 2009 | 38 | 0.080 |
Why?
| Abortion, Therapeutic | 1 | 2008 | 3 | 0.080 |
Why?
| Efficiency, Organizational | 1 | 2009 | 41 | 0.080 |
Why?
| Recurrence | 1 | 2010 | 662 | 0.080 |
Why?
| Electrocardiography | 1 | 2010 | 262 | 0.080 |
Why?
| Cardiac Catheterization | 1 | 2010 | 214 | 0.080 |
Why?
| Atrial Fibrillation | 1 | 2011 | 183 | 0.080 |
Why?
| Sus scrofa | 2 | 2024 | 33 | 0.080 |
Why?
| Toxicity Tests | 1 | 2008 | 54 | 0.080 |
Why?
| Spinal Cord Compression | 1 | 2008 | 10 | 0.080 |
Why?
| Cervix Uteri | 1 | 2008 | 49 | 0.080 |
Why?
| Autopsy | 1 | 2008 | 47 | 0.080 |
Why?
| Takayasu Arteritis | 1 | 2008 | 2 | 0.080 |
Why?
| Gynecologic Surgical Procedures | 1 | 2008 | 30 | 0.080 |
Why?
| Veins | 1 | 2008 | 71 | 0.080 |
Why?
| Evaluation Studies as Topic | 1 | 2008 | 110 | 0.080 |
Why?
| Arteries | 1 | 2008 | 92 | 0.080 |
Why?
| Delivery, Obstetric | 1 | 2009 | 122 | 0.080 |
Why?
| Internet | 1 | 2010 | 258 | 0.070 |
Why?
| Pregnancy Complications, Cardiovascular | 1 | 2008 | 35 | 0.070 |
Why?
| Costs and Cost Analysis | 1 | 2007 | 91 | 0.070 |
Why?
| Rabbits | 1 | 2008 | 374 | 0.070 |
Why?
| Attitude to Health | 1 | 2009 | 191 | 0.070 |
Why?
| Ultrasonography | 1 | 2009 | 437 | 0.070 |
Why?
| Uterus | 1 | 2007 | 94 | 0.070 |
Why?
| Coronary Artery Disease | 1 | 2010 | 276 | 0.070 |
Why?
| Sheep | 3 | 2011 | 90 | 0.070 |
Why?
| Cells, Cultured | 1 | 2008 | 1581 | 0.060 |
Why?
| Swine Diseases | 1 | 2024 | 7 | 0.060 |
Why?
| Severity of Illness Index | 2 | 2018 | 951 | 0.060 |
Why?
| Immunocompromised Host | 1 | 2024 | 119 | 0.060 |
Why?
| Prevalence | 2 | 2020 | 951 | 0.050 |
Why?
| Inflammation | 2 | 2017 | 604 | 0.050 |
Why?
| Leg | 1 | 2022 | 122 | 0.050 |
Why?
| Infant, Low Birth Weight | 1 | 2022 | 62 | 0.050 |
Why?
| ABO Blood-Group System | 1 | 2021 | 15 | 0.050 |
Why?
| Heart Rate | 1 | 2022 | 298 | 0.050 |
Why?
| Bayes Theorem | 1 | 2021 | 109 | 0.050 |
Why?
| Colorado | 1 | 2020 | 21 | 0.050 |
Why?
| Magnetic Resonance Imaging | 1 | 2008 | 1541 | 0.050 |
Why?
| Health Policy | 1 | 2021 | 154 | 0.050 |
Why?
| Gestational Age | 1 | 2022 | 418 | 0.050 |
Why?
| Splints | 1 | 2019 | 6 | 0.040 |
Why?
| Casts, Surgical | 1 | 2019 | 8 | 0.040 |
Why?
| Anesthesia, Local | 1 | 2019 | 15 | 0.040 |
Why?
| Endocrine System | 1 | 2019 | 16 | 0.040 |
Why?
| Click Chemistry | 1 | 2018 | 3 | 0.040 |
Why?
| Azides | 1 | 2018 | 10 | 0.040 |
Why?
| Staining and Labeling | 1 | 2018 | 97 | 0.040 |
Why?
| Cardioplegic Solutions | 1 | 2017 | 3 | 0.040 |
Why?
| Chronic Disease | 2 | 2010 | 571 | 0.040 |
Why?
| Computer Systems | 1 | 2017 | 21 | 0.040 |
Why?
| Enterococcus | 1 | 2017 | 10 | 0.040 |
Why?
| Antiphospholipid Syndrome | 1 | 2016 | 9 | 0.040 |
Why?
| Epithelial Cells | 1 | 2018 | 207 | 0.030 |
Why?
| Pneumonectomy | 1 | 2016 | 30 | 0.030 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2016 | 69 | 0.030 |
Why?
| Area Under Curve | 1 | 2016 | 178 | 0.030 |
Why?
| Endothelial Cells | 1 | 2018 | 270 | 0.030 |
Why?
| Specialties, Surgical | 1 | 2016 | 33 | 0.030 |
Why?
| Creatine Kinase, MB Form | 1 | 2015 | 6 | 0.030 |
Why?
| Angiography | 1 | 2016 | 130 | 0.030 |
Why?
| Academic Medical Centers | 1 | 2016 | 147 | 0.030 |
Why?
| Wound Healing | 1 | 2016 | 205 | 0.030 |
Why?
| Predictive Value of Tests | 1 | 2016 | 905 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2015 | 581 | 0.030 |
Why?
| Mice, Inbred C57BL | 1 | 2019 | 1819 | 0.030 |
Why?
| Microscopy, Electron, Scanning | 1 | 2012 | 48 | 0.030 |
Why?
| Logistic Models | 1 | 2015 | 889 | 0.030 |
Why?
| Cholangiopancreatography, Magnetic Resonance | 1 | 2012 | 9 | 0.030 |
Why?
| Pancreaticoduodenectomy | 1 | 2012 | 10 | 0.030 |
Why?
| Cohort Studies | 1 | 2016 | 1422 | 0.030 |
Why?
| Length of Stay | 1 | 2015 | 621 | 0.030 |
Why?
| Sheep, Domestic | 1 | 2011 | 12 | 0.030 |
Why?
| Databases, Factual | 1 | 2015 | 657 | 0.020 |
Why?
| Rupture | 1 | 2011 | 24 | 0.020 |
Why?
| Salaries and Fringe Benefits | 1 | 2010 | 8 | 0.020 |
Why?
| Polystyrenes | 1 | 2010 | 4 | 0.020 |
Why?
| Injections, Intra-Arterial | 1 | 2010 | 13 | 0.020 |
Why?
| Microspheres | 1 | 2010 | 26 | 0.020 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 32 | 0.020 |
Why?
| Pulmonary Veins | 1 | 2011 | 33 | 0.020 |
Why?
| Models, Biological | 1 | 2014 | 723 | 0.020 |
Why?
| Job Satisfaction | 1 | 2010 | 35 | 0.020 |
Why?
| Certification | 1 | 2010 | 49 | 0.020 |
Why?
| Mitral Valve Insufficiency | 1 | 2010 | 45 | 0.020 |
Why?
| Enzyme Activation | 1 | 2010 | 275 | 0.020 |
Why?
| Single-Blind Method | 1 | 2010 | 115 | 0.020 |
Why?
| Stroke Volume | 1 | 2010 | 129 | 0.020 |
Why?
| Ventricular Function, Left | 1 | 2010 | 159 | 0.020 |
Why?
| Hysterectomy | 1 | 2009 | 88 | 0.020 |
Why?
| Diagnostic Imaging | 1 | 2011 | 177 | 0.020 |
Why?
| Blotting, Western | 1 | 2010 | 601 | 0.020 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 595 | 0.020 |
Why?
| Phosphorylation | 1 | 2010 | 534 | 0.020 |
Why?
| Up-Regulation | 1 | 2010 | 453 | 0.020 |
Why?
| Pregnancy Tests | 1 | 2008 | 2 | 0.020 |
Why?
| Uterine Hemorrhage | 1 | 2008 | 11 | 0.020 |
Why?
| Chorionic Gonadotropin | 1 | 2008 | 18 | 0.020 |
Why?
| Heart Ventricles | 1 | 2010 | 251 | 0.020 |
Why?
| Sex Factors | 1 | 2010 | 697 | 0.020 |
Why?
| Treatment Failure | 1 | 2008 | 116 | 0.020 |
Why?
| Cesarean Section | 1 | 2009 | 187 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2010 | 1185 | 0.020 |
Why?
| Pregnancy Outcome | 1 | 2008 | 237 | 0.020 |
Why?
| Pregnancy Complications | 1 | 2009 | 382 | 0.010 |
Why?
|
|
Rajab's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
|